TileDB and Strand Life Sciences: Solving Genomic Data Bottlenecks with Unified Data Architecture and AI Analytics

Since the completion of the Human Genome Project, genome sequencing has drastically evolved, generating vast amounts of genomic data that pose significant management challenges due to their size and complexity. TileDB's Carrara platform addresses these challenges with a unified data architecture that integrates multi-omics datasets into a single environment, promoting efficient querying, secure sharing, and scalable computation in line with FAIR principles. This platform supports collaboration by ensuring high regulatory and security standards, making it a strong foundation for genomic research. Complementing this, Strand Life Sciences offers automated bioinformatics workflows that leverage AI to transform raw omics data into formats ready for analysis, applying advanced models for drug sensitivity and biomarker discovery. The synergy between TileDB’s robust data management capabilities and Strand’s analytical expertise presents a promising opportunity to streamline genomic data workflows, enhance data governance, and accelerate research in precision medicine and drug discovery.